CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer-Reference-Cited by-同舟云学术

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer

Published:2015-09-28 Issue:9 Volume:10 Page:e0139237
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Devapatla Bharat,Sharma Ankur,Woo Sukyung

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. The prognostic significance of angiogenesis in epithelial ovarian carcinoma;AA Alvarez;Clin Cancer Res,1999

2. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy;D Hazelton;Clin Cancer Res,1999

3. Angiogenesis in normal and neoplastic ovaries;S Ramakrishnan;Angiogenesis,2005

4. Angiogenesis in ovarian cancer;MR Brown;Bailliere's best practice & research Clinical obstetrics & gynaecology,2000

5. Angiogenesis and ovarian cancer;C Gomez-Raposo;Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,2009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCL3/TGF-β-mediated crosstalk between CAFs and tumor cells augments RCC progression and sunitinib resistance;iScience;2024-07

2. Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations;International Journal of Biological Macromolecules;2024-05

3. CXCR2 inhibition overcomes ponatinib intolerance by eradicating chronic myeloid leukemic stem cells through PI3K/Akt/mTOR and dipeptidylpeptidase Ⅳ (CD26);Heliyon;2023-11

4. Harnessing neutrophil plasticity for HCC immunotherapy;Essays in Biochemistry;2023-09

5. Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer;Biomedicines;2023-08-16